Trial intelligence / Profile preview

Optimizing Ropivacaine Concentration for Sciatic Nerve Blocks

NCT01898689Phase 4Completed

Sponsor
University of California, San Diego
Start
Jul 2013
Primary completion
Nov 2013
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of California, San Diego. Started Jul 2013; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01898689.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01898689.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call